• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Crispr Therapeutics Ag (NQ: CRSP )

    53.10 -0.80 (-1.48%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Crispr Therapeutics Ag

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    26 27 Next >
    CRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024
    CRSP stock results show that CRISPR Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
    Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments. 
    Via InvestorPlace
    Exposures Product Safety
    Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
    The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
    Via InvestorPlace
    3 Growth Stocks You’ll Kick Yourself for Not Buying Today
    Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns. 
    Via InvestorPlace
    3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
    It pays to develop novel medicines for life-threatening illnesses. 
    Via The Motley Fool
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today
    Via Benzinga
    Is It Too Late to Buy CRISPR Therapeutics Stock?
    The biotech has been making a lot of noise since late last year. 
    Via The Motley Fool
    3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
    Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
    Via InvestorPlace
    Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
    A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount. 
    Via InvestorPlace
    Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
    Good news could be just around the corner for two drugmakers not named Novo Nordisk. 
    Via The Motley Fool
    Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
    Vertex is broadening its portfolio. 
    Via The Motley Fool
    3 Magnificent Stocks That Could Double or More by 2030
    There's no guarantee these stocks will double by 2030, but their growth prospects look great. 
    Via The Motley Fool
    Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
    In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024. 
    Via InvestorPlace
    Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
    These rising drugmakers have serious arguments in their favor. 
    Via The Motley Fool
    Bull Market and Beyond: 3 Stocks Just Waiting to Soar
    These stocks, a bargain today, are players to hold on to for the long term. 
    Via The Motley Fool
    Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
    These companies are in the early days of their growth stories. 
    Via The Motley Fool
    3 Unstoppable Stocks to Buy Hand Over Fist in April
    These stocks have exceptionally bright prospects. 
    Via The Motley Fool
    Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why
    The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia. 
    Via Investor's Business Daily
    3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
    Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine. 
    Via InvestorPlace
    3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
    Each of these three companies are entering a new era of growth. 
    Via The Motley Fool
    Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
    The price could be right for these three biopharma stocks. 
    Via The Motley Fool
    3 Stocks That Could Be the Next Big Thing in Gene Editing
    Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks. 
    Via InvestorPlace
    The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024
    These undervalued Cathie Wood stocks capture her favorite trends and remain undervalued even as the wider tech sector surge. 
    Via InvestorPlace
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation. 
    Via InvestorPlace
    Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
    On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new 
    Via Benzinga
    It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
    Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
    Via Talk Markets
    The Top 3 Biotech Stocks to Buy in March 2024
    Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors. 
    Via InvestorPlace
    Here's Why CRISPR Therapeutics Stock Climbed 34% in February
    The biotech company keeps moving closer to bringing its promising first gene therapy to market. 
    Via The Motley Fool
    ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
    Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst
    This company's fortunes are likely to improve, and soon. 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    26 27 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.